Literature DB >> 19215006

Predictors of stroke risk in native Chinese with nonrheumatic atrial fibrillation: retrospective investigation of hospitalized patients.

Yihong Sun1, Dayi Hu, Kuibao Li, Ziqiang Zhou.   

Abstract

BACKGROUND: Data on stroke risk factor profiles and atrial fibrillation (AF) for the Chinese population are sparse. This study identified risk factors for stroke among native Chinese with nonrheumatic AF.
METHODS: In this retrospective investigation, patients diagnosed with nonrheumatic AF were identified from 18 hospitals in representative areas of the country, from January 2000 to April 2002, based on the medical records. All parameters relevant to AF were compared between AF patients with stroke and those without. The independent risk factors for stroke were assessed with a logistic regression analysis.
RESULTS: Patients numbering 3,425 with AF were included, among whom 827 subjects were discharged on account of stroke. The prevalence of stroke in nonrheumatic AF patients was 24.15%. AF patients with stroke were significantly older than controls (73.31 +/- 9.18 versus 68.22 +/- 12.29 y, p < 0.001) and more likely to have a history of hypertension (71.0 versus 51.6%, p < 0.001) and diabetes (17.9 versus 11.1%, p = 0.001).Both, systolic and diastolic blood pressure, are significantly higher in patients with stroke. Of all the parameters of echocardiography, there was strong evidence that left atrial (LA) thrombi significantly increased risk of stroke. Patients with persistent AF were more likely to have stroke than paroxysmal AF patients, while lone AF is less in patients with stroke than in those without. The rate of anticoagulation treatment is only 9.27%, but there were no significant differences between the 2 groups. In multivariate analysis, age > or = 75 y (odds ratio [OR] 1.76; 95% confidence interval [CI] 1.08-2.98), history of hypertension (OR 1.52; 95% CI 1.28-1.80), diabetes (OR 1.39; 95% CI 1.11-1.76), high systolic blood pressure (OR 1.71; 95% CI 1.21-2.28), LA thrombi (OR 2.77; 95% CI 1.25-6.13) were independent predictors for stroke.
CONCLUSIONS: The prevalence of stroke in hospitalized nonrheumatic AF patients was high. The population-specific risk factors for stroke were age > or = 75 y, diabetes, history of hypertension, high systolic blood pressure and LA thrombi by transesophageal echocardiography (TEE). These merit further evaluation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19215006      PMCID: PMC6652905          DOI: 10.1002/clc.20232

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  16 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.

Authors:  Robby Nieuwlaat; Alessandro Capucci; A John Camm; S Bertil Olsson; Dietrich Andresen; D Wyn Davies; Stuart Cobbe; Günter Breithardt; Jean-Yves Le Heuzey; Martin H Prins; Samuel Lévy; Harry J G M Crijns
Journal:  Eur Heart J       Date:  2005-10-04       Impact factor: 29.983

3.  Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.

Authors:  R G Hart; O Benavente; R McBride; L A Pearce
Journal:  Ann Intern Med       Date:  1999-10-05       Impact factor: 25.391

4.  Retrospective investigation of hospitalised patients with atrial fibrillation in mainland China.

Authors:  Q I Wen-Hang
Journal:  Int J Cardiol       Date:  2005-12-07       Impact factor: 4.164

5.  Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.

Authors:  R G Hart; L A Pearce; R McBride; R M Rothbart; R W Asinger
Journal:  Stroke       Date:  1999-06       Impact factor: 7.914

6.  Major causes of death among men and women in China.

Authors:  Jiang He; Dongfeng Gu; Xigui Wu; Kristi Reynolds; Xiufang Duan; Chonghua Yao; Jialiang Wang; Chung-Shiuan Chen; Jing Chen; Rachel P Wildman; Michael J Klag; Paul K Whelton
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

7.  Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.

Authors:  A S Go; E M Hylek; K A Phillips; L H Borowsky; L E Henault; Y Chang; J V Selby; D E Singer
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

8.  Antithrombotic treatment of atrial fibrillation in a regional hospital in Hong Kong.

Authors:  C S Leung; K M Tam
Journal:  Hong Kong Med J       Date:  2003-06       Impact factor: 2.227

9.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

10.  Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders.

Authors: 
Journal:  Stroke       Date:  1989-10       Impact factor: 7.914

View more
  7 in total

1.  Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.

Authors:  Yutao Guo; Hao Wang; Yingchun Tian; Yutang Wang; Gregory Y H Lip
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

2.  Clinical characteristics and impact of diabetes mellitus on outcomes in patients with nonvalvular atrial fibrillation.

Authors:  Bi Huang; Yanmin Yang; Jun Zhu; Yan Liang; Han Zhang; Li Tian; Xinghui Shao; Juan Wang
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

3.  Rationale and design of the improving Care for Cardiovascular Disease in China (CCC) project: a national registry to improve management of atrial fibrillation.

Authors:  Yongchen Hao; Jing Liu; Sidney C Smith; Yong Huo; Gregg C Fonarow; Junbo Ge; Jun Liu; Kathryn A Taubert; Louise Morgan; Yang Guo; Mengge Zhou; Dong Zhao; Changsheng Ma
Journal:  BMJ Open       Date:  2018-07-05       Impact factor: 2.692

4.  Impact of age on thromboembolic events in patients with non-valvular atrial fibrillation.

Authors:  Yun Gi Kim; Jong-Il Choi; Ki Yung Boo; Do Young Kim; Yeji Hong; Min Sun Kim; Kwang-No Lee; Jaemin Shim; Jin Seok Kim; Young-Hoon Kim
Journal:  Clin Cardiol       Date:  2019-11-15       Impact factor: 2.882

5.  Prognostic significance of diabetes mellitus in patients with atrial fibrillation.

Authors:  Andreas S Papazoglou; Anastasios Kartas; Athanasios Samaras; Ioannis Vouloagkas; Eleni Vrana; Dimitrios V Moysidis; Evangelos Akrivos; Georgios Kotzampasis; Amalia Baroutidou; Anastasios Papanastasiou; Evangelos Liampas; Michail Botis; Efstratios Karagiannidis; Nikolaos Stalikas; Haralambos Karvounis; Apostolos Tzikas; George Giannakoulas
Journal:  Cardiovasc Diabetol       Date:  2021-02-11       Impact factor: 9.951

Review 6.  Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation.

Authors:  Andreas S Papazoglou; Anastasios Kartas; Dimitrios V Moysidis; Christos Tsagkaris; Stavros P Papadakos; Alexandra Bekiaridou; Athanasios Samaras; Efstratios Karagiannidis; Marios Papadakis; George Giannakoulas
Journal:  Cardiovasc Diabetol       Date:  2022-03-14       Impact factor: 9.951

7.  The prevalence, incidence, management and risks of atrial fibrillation in an elderly Chinese population: a prospective study.

Authors:  Li-Hua Li; Chang-Sheng Sheng; Bang-Chuan Hu; Qi-Fang Huang; Wei-Fang Zeng; Ge-Le Li; Ming Liu; Fang-Fei Wei; Lu Zhang; Yuan-Yuan Kang; Jie Song; Shuai Wang; Yan Li; Shao-Wen Liu; Ji-Guang Wang
Journal:  BMC Cardiovasc Disord       Date:  2015-05-08       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.